증후성 멀티플렉스 진단 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Syndromic Multiplex Diagnostic Trends and Forecast

The future of the global syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets. The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

A more than 150-page report is developed to help in your business decisions.

Syndromic Multiplex Diagnostic by Segment

The study includes a forecast for the global syndromic multiplex diagnostic by type, end use, and region.

Syndromic Multiplex Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Respiratory
• Gastrointestinal
• Central Nervous System
• Others

Syndromic Multiplex Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Others

Syndromic Multiplex Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Syndromic Multiplex Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies syndromic multiplex diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the syndromic multiplex diagnostic companies profiled in this report include-

• Biomerieux
• Qiagen
• Diasorin S.P.A
• Applied Biocode
• Akonni Biosystems
• Thermo Fisher Scientific
• Abbott Laboratories
• Accelerate Diagnostic
• Becton and Dickinson
• Hologic

Syndromic Multiplex Diagnostic Market Insights

Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Within this market, hospitals is expected to remain the largest segment due to the high volume of diagnostic tests performed in hospitals.

North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Features of the Global Syndromic Multiplex Diagnostic Market

Market Size Estimates: Syndromic multiplex diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Syndromic multiplex diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Syndromic multiplex diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the syndromic multiplex diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the syndromic multiplex diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the syndromic multiplex diagnostic market size?

Answer: The global syndromic multiplex diagnostic market is expected to reach an estimated $4.25 billion by 2030.

Q2. What is the growth forecast for syndromic multiplex diagnostic market?

Answer: The global syndromic multiplex diagnostic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the syndromic multiplex diagnostic market?

Answer: The major drivers for this market are increasing prevalence of infectious disease, rising adoption of molecular diagnostic techniques, and growing demand for accurate and rapid results and quick access to the treatment.

Q4. What are the major segments for syndromic multiplex diagnostic market?

Answer: The future of the syndromic multiplex diagnostic market looks promising with opportunities in the hospitals and diagnostics laboratories markets.

Q5. Who are the key syndromic multiplex diagnostic market companies?

Answer: Some of the key syndromic multiplex diagnostic companies are as follows:

• Biomerieux
• Qiagen
• Diasorin S.P.A
• Applied Biocode
• Akonni Biosystems
• Thermo Fisher Scientific
• Abbott Laboratories
• Accelerate Diagnostic
• Becton and Dickinson
• Hologic

Q6. Which syndromic multiplex diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that gastrointestinal will remain the larger segment over the forecast period as it helps in identifing pathogens responsible for diseases like gastroenteritis and foodborne illnesses.

Q7. In syndromic multiplex diagnostic market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region during the forecast period due to rising healthcare expenditure, growing demand for early and accurate diagnosis, and increasing prevalence of various communicable or non-communicable diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the syndromic multiplex diagnostic market by type (respiratory, gastrointestinal, central nervous system, and others), end use (hospitals, diagnostics laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Syndromic Multiplex Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Syndromic Multiplex Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Syndromic Multiplex Diagnostic Market by Type
  • 3.3.1: Respiratory
  • 3.3.2: Gastrointestinal
  • 3.3.3: Central Nervous System
  • 3.3.4: Others
• 3.4: Global Syndromic Multiplex Diagnostic Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Diagnostics Laboratories
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Syndromic Multiplex Diagnostic Market by Region
• 4.2: North American Syndromic Multiplex Diagnostic Market
  • 4.2.2: North American Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.3: European Syndromic Multiplex Diagnostic Market
  • 4.3.1: European Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.3.2: European Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.4: APAC Syndromic Multiplex Diagnostic Market
  • 4.4.1: APAC Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.4.2: APAC Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others
• 4.5: ROW Syndromic Multiplex Diagnostic Market
  • 4.5.1: ROW Syndromic Multiplex Diagnostic Market by Type: Respiratory, Gastrointestinal, Central Nervous System, and Others
  • 4.5.2: ROW Syndromic Multiplex Diagnostic Market by End Use: Hospitals, Diagnostics Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by End Use
  • 6.1.3: Growth Opportunities for the Global Syndromic Multiplex Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Syndromic Multiplex Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Syndromic Multiplex Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Syndromic Multiplex Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: BioMerieux
• 7.2: Qiagen
• 7.3: DiaSorin S.p.A
• 7.4: Applied BioCode
• 7.5: Akonni Biosystems
• 7.6: Thermo Fisher Scientific
• 7.7: Abbott Laboratories
• 7.8: Accelerate Diagnostic
• 7.9: Becton and Dickinson
• 7.10: Hologic